Arrakis Therapeutics

Operator of a healthcare database platform intended for commercial teams to accelerate the adoption of lifesaving technologies. The company's platform provides physician and account data through its business software and data tools to identify relevant leads, target valuable accounts, and estimate territory potential, enabling clients' sales teams to commercialize life-saving products to healthcare providers.

Developer of novel drug designed for doctors to treat neurodegenerative diseases. The company develops treatments that modulate mitophagy and autophagy by leveraging an understanding of critical neural pathways to discover and develop novel small molecules that will restore cellular balance and target lysosomes to modulate and restore their activity to prevent neurodegenerative diseases, enabling physicians to improve the lives of patients suffering from a range of neurodegenerative diseases and senescence.

Heptares Therapeutics develops novel, small-molecule drugs for G-protein-coupled receptors (GPCRs).